BRIO is the Integrated Cancer Research Site (SIRIC) of Bordeaux. It brings together on a single site multidisciplinary research teams working in synergy to produce new knowledge in oncology and accelerate their transfer to the benefit of patients.
BRIO is one of eight sites labeled by the INCa (The French National Cancer Institute) for 2018-2022. This second label has been attributed, among other things, to its selection process for innovative research programs. BRIO identified 27 international experts and submitted 9 interdisciplinary research programs to them. Three programs have been selected:
Through these programs, BRIO mobilizes the skills of researchers in fields that are involved, beyond biology, in the fight against cancer:
Humanities and Social Sciences, public health, epidemiology, clinical, physical sciences, chemistry, mathematics, computer science…
BRIO has also distinguished itself by its strategy of bringing patients closer to its approach. He notably included in his Trustees Committee and in its Dissemination and Mediation Committee of the patients who accompany BRIO in its management and actions. He also initiated in 2016, a collective named ASPERON & CO (Associations and Patients Engaged for Research in Oncology & Professional Community). This community brings together over 60 patients, former patients, caregivers, association volunteers and health and research professionals. Together, they imagine and carry out projects to improve collaboration and communication in cancer research. BRIO relies on the ideas of and members of ASPERON & CO for its mission of valorization and dissemination of the know-how and results of research in oncology.
BRIO participates in the structuring of the cancer research community in Bordeaux and New Aquitaine which is currently reflected in the Oncosphere project.